Skip to content
The GLP-1 Verdict
Menu
Ranked #304 · Grade C

MyStart Health review

A fast-onboarding compounded GLP-1 service with a genuine dose price-lock, undermined by quiz-gated pricing, unnamed pharmacies and an FDA warning letter from September 2025.

MyStart Health — FDA warning letter, September 2025. Addressed to Matthew Stern, CEO MyStart Health LLC., and public in FDA’s warning-letter database.

Visit MyStart Health Assume we may earn a commission, at no cost to you. It never changes The Verdict Score, nor a word of this review.
Semaglutide
From $299/mo (per-drug price quiz-gated)
Tirzepatide
From $299/mo (per-drug price quiz-gated)
Coverage
Multi-state
Brand-name
Compounded only

The scorecard

MyStart Health scored on our six published factors. See the methodology.

Real-world results58/100
Price honesty58/100
Prescriber access80/100
Formulary choice58/100
Cancellation fairness58/100
Member support68/100

What we like

  • The price-lock is stated plainly: 'the price of medication and ongoing care will never increase from your base plan amount, EVEN if your dosage increases in subsequent months'
  • Roughly five-minute intake with a prescription inside 24 hours or a same-day video consultation
  • The $299 base covers physician evaluations, follow-ups, unlimited clinician messaging, medication, any necessary blood work and shipping
  • Publishes a clear Section 503A compounding disclosure stating the medications are not FDA-approved or FDA-evaluated for safety, effectiveness or quality
  • Phone and email support with published weekday and Saturday hours, plus 24/7 care-team access

The caveats

  • FDA issued a warning letter to Matthew Stern, CEO MyStart Health LLC. in September 2025; it is public in FDA's warning-letter database
  • Compounded only — no FDA-approved Ozempic, Wegovy, Mounjaro or Zepbound, and no oral route
  • Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety, effectiveness or quality
  • Only the '$299/month, excluding any discounts' floor is published; per-drug plan pricing sits behind the quiz and a signed medical-accuracy attestation, and payment is taken before the clinician review
  • Refund Policy effective 1 December 2025 makes shipped orders strictly non-refundable and non-returnable under any circumstances; pharmacy partners are described only as 'independent third-party pharmacies'

The verdict

Best for: Someone who values speed of onboarding above price transparency and is content to be billed before a clinician has reviewed them. A fast-onboarding compounded GLP-1 service with a genuine dose price-lock, undermined by quiz-gated pricing, unnamed pharmacies and an FDA warning letter from September 2025.

Ranked #304 of 539 providers we have reviewed — for comparison, read the CoreAge Rx review, our #1 pick. In the ranking it sits between Lttl at #303, 61/100 above and Fresh Day Meds at #305, 63/100 below, with the Trillium Meds ruling the next one down.

A grade C is a ranking, not an instruction to stop looking: the closest rivals to MyStart Health are ruled on the identical rubric, so the comparison is like for like.This ruling sits inside a bigger one: the complete ranking puts this ruling in context against every program we track. We have also ruled on it directly: CoreAge Rx vs MyStart Health goes to CoreAge Rx, 94/100 to 63/100.

Compare with other providers

The closest rulings to MyStart Health by Verdict Score — the realistic shortlist if you are weighing this one up.

Browse all 539 rulings, ranked →

Pricing, states and verification reflect MyStart Health's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on MyStart Health's site. Not medical advice; see our disclosure.

← Back to all rankings